Harbor Capital Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,339
| Closed | -$230K | – | 1521 |
|
|
2024
Q4 | $230K | Sell |
42,339
-3,399
| -7% | -$18.5K | 0.01% | 641 |
|
|
2024
Q3 | $330K | Buy |
45,738
+8,166
| +22% | +$58.9K | 0.01% | 625 |
|
|
2024
Q2 | $408K | Buy |
37,572
+11,409
| +44% | +$124K | 0.03% | 565 |
|
|
2024
Q1 | $490K | Sell |
26,163
-2,322
| -8% | -$43.5K | 0.06% | 399 |
|
|
2023
Q4 | $617K | Sell |
28,485
-6,288
| -18% | -$136K | 0.12% | 211 |
|
|
2023
Q3 | $716K | Buy |
34,773
+13,720
| +65% | +$282K | 0.15% | 168 |
|
|
2023
Q2 | $990K | Buy |
+21,053
| New | +$990K | 0.2% | 131 |
|